Buy Epitalon 100 mg + Bacteriostatic Water

€231.10

Epitalon, 100 mg, with bacteriostatic water, is a synthetic Ala-Glu-Asp-Gly tetrapeptide for analytical and in vitro laboratory research. Pharma Research .eu provides documented European supply subject to lot-specific purity, identity and salt-form verification.

Category:
Description

Buy Epitalon, 100 mg + Bacteriostatic Water, for Advanced Laboratory Research in Europe

Epitalon, also written Epithalon, is a synthetic linear tetrapeptide comprising Ala-Glu-Asp-Gly, abbreviated AEDG. It is supplied as a laboratory reagent for peptide analytics, physicochemical characterisation and controlled in vitro investigations of peptide-associated cellular pathways. The commonly reported free-peptide formula is C₁₄H₂₂N₄O₉, with average molecular mass approximately 390.35 Da and CAS Registry Number 307297-39-8. Pharma Research .eu presents this 100 mg format with bacteriostatic water for qualified European laboratory teams.drugs.ncats+2

Uncompromising Purity and Analytical Characterisation

Epitalon should be specified as the linear tetrapeptide:

H-Ala-Glu-Asp-Gly-OH

The commonly reported material is the free peptide with L-alanine, L-glutamic acid, L-aspartic acid and glycine residues. The terminal groups and stereochemistry should be stated explicitly. Acetylated, amidated, trifluoroacetate or other salt forms are different analytical materials and may have different formulae, molecular masses, charge states and chromatographic behaviour. For example, Epitalon TFA is reported separately with a molecular mass around 504.37 g/mol.pubchem.ncbi.nlm.nih+1

For laboratory procurement, the suitable target is ≥99.0% purity by RP-HPLC, subject to confirmation by the actual batch-specific certificate of analysis. The supplier should not transfer a free-peptide purity or mass specification to an acetate, TFA or hydrated form without supporting documentation.

A complete CoA should include:

  • RP-HPLC purity percentage, analytical method and chromatogram.

  • LC-MS, ESI-MS or high-resolution MS identity confirmation.

  • Full sequence and terminal-group designation.

  • Stereochemical configuration of each amino-acid residue.

  • Free-peptide, TFA, acetate or other salt-form information.

  • Molecular formula and molecular-mass assignment.

  • Visual appearance of the lyophilised material.

  • Residual-solvent results from synthesis and purification.

  • Water or residual-moisture content, where measured.

  • Heavy-metal or elemental-impurity results where included in the quality programme.

  • Lot number, manufacture date, retest date and storage requirements.

The free-peptide formula is commonly reported as C₁₄H₂₂N₄O₉, with average molecular mass approximately 390.35 g/mol and exact mass near 390.1387 Da. CAS Registry Number 307297-39-8 is widely associated with Epitalon. The supplier’s CoA should control the final identity statement, particularly if a counter-ion or hydrate is present.drugs.ncats+2

Epitalon is normally supplied as a white to off-white lyophilised powder. Visual inspection can identify gross discolouration, vial damage or visible contamination, but cannot establish identity or purity. Analytical release should combine appearance assessment with RP-HPLC and mass-spectral confirmation.

High purity is important because short acidic peptides can contain deletion sequences, altered terminal groups, residual synthesis materials, counter-ions and moisture. These components can affect retention time, ionisation, sample recovery and concentration calculations. A 100 mg presentation should also be supported by accurate net-content measurement rather than relying only on nominal vial fill.

Bacteriostatic water is a separate reagent and should have its own label, expiry date, preservative information and documentation. Its excipients may influence chromatography, ionisation, adsorption, pH or cellular assay performance.

Principal Laboratory Applications and Research Methodologies

Epitalon is suitable for controlled laboratory research involving tetrapeptide chemistry, analytical characterisation and in vitro biochemical model development. All applications should be conducted by qualified personnel within an appropriately governed university, CRO, pharmaceutical R&D or analytical laboratory.

RP-HPLC and LC-MS method development. Epitalon can serve as a defined low-molecular-weight peptide analyte for retention-time assignment, chromatographic optimisation, intact-mass confirmation and impurity profiling. Its acidic residues may require optimisation of mobile-phase pH, ionic strength and column chemistry.

Peptide identity and degradation profiling. Laboratories may monitor hydrolysis-related species, deletion products, oxidation products and other stress-related impurities using combined HPLC and mass spectrometry. A validated method should distinguish chemical degradation from adsorption, incomplete dissolution, matrix effects and instrument carryover.

In vitro cellular and biochemical models. A verified Epitalon lot may be incorporated into controlled cell-free or cellular systems examining peptide-associated biochemical responses or pathway read-outs. Experimental plans should include vehicle controls, blank matrices, concentration confirmation and independent assessment of peptide integrity during incubation.

Reference and system-suitability work. A documented batch may support instrument checks, calibration development, retention-time comparison and sample-preparation validation. Unless formally certified under a recognised reference-material standard, it should be described as a research reference material or analytical reagent rather than a certified reference material.

The 100 mg quantity corresponds to approximately 256 µmol using the reported average molecular mass of 390.35 g/mol. If the measured net content, salt form or hydration state differs, the molar amount should be recalculated using the CoA. No working concentration should be stated without a specified final volume and validated preparation method.

Bacteriostatic water should not automatically be assumed suitable for every analytical or cellular workflow. Preservatives may require solvent blanks, matrix-effect studies and cell-compatibility testing. Laboratories should select and validate the reconstitution medium for the intended method.

Compound Stability, Optimal Storage, and Safe Handling Protocols

Epitalon should remain sealed in its lyophilised state until required for a validated laboratory procedure. Research guidance commonly recommends storing the dry peptide at approximately −20°C, protected from light and moisture. Prepared solutions require separate stability verification because pH, container material, concentration and storage history can influence recovery.coaindex+2

Recommended controls include:

  • Store unopened lyophilised Epitalon at approximately −20°C unless the CoA specifies otherwise.

  • Consider −80°C for extended archival storage where supported by the laboratory stability programme.

  • Keep the container tightly closed, dry and protected from direct light.

  • Allow a sealed vial to reach room temperature before opening to minimise condensation.

  • Use low-binding tubes where adsorption could affect recovery.

  • Prepare aliquots if repeated access is expected.

  • Store short-term aqueous solutions at 2–8°C only where validated.

  • Use frozen aliquots for longer-term solution storage when supported by stability data.

  • Avoid repeated freeze–thaw cycles.

  • Record solvent, concentration, preparation date, operator and storage history.

Epitalon’s acidic residues can influence solubility, pH and adsorption depending on the selected solvent and container. Apparent loss from solution may reflect surface binding or altered chromatographic recovery rather than chemical decomposition. Stability should therefore be assessed using HPLC or LC-MS rather than visual appearance alone.

Reconstitution should be performed using a validated laboratory procedure. Add bacteriostatic water gradually, allow the powder to hydrate and mix gently. Avoid vigorous agitation unless its compatibility has been demonstrated. Confirm concentration and chromatographic integrity after preparation where quantitative results are required.

Handling should follow the current SDS and institutional chemical-risk assessment. Appropriate precautions generally include a certified fume hood or suitable local containment, nitrile gloves, safety goggles and a laboratory coat. Avoid aerosol generation and direct contact with the powder or solution. Dispose of contaminated materials through approved institutional chemical and laboratory-waste procedures.

Technical Specifications and Molecular Attributes

Attribute Specification
Product Epitalon, 100 mg, supplied with bacteriostatic water
Common designation Epitalon; Epithalon; AEDG peptide
Sequence H-Ala-Glu-Asp-Gly-OH
Residue count 4 amino acids
IUPAC name Full systematic peptide name should be confirmed on the CoA; sequence notation is preferred for procurement
CAS Registry Number 307297-39-8
Molecular formula, free peptide C₁₄H₂₂N₄O₉
Average molecular mass Approximately 390.35 g/mol
Exact mass Approximately 390.1387 Da
Physical state and colour Lyophilised white to off-white powder
Solubility profile Aqueous reconstitution may be feasible; solvent and buffer compatibility require assay-specific validation
Typical purity Proposed target ≥99.0% by RP-HPLC; verify the actual lot-specific result
Identity testing LC-MS, ESI-MS or high-resolution MS
Companion reagent Bacteriostatic water; volume and formulation should be confirmed on the packaging
Long-term storage Typically −20°C, sealed and protected from light and moisture

If the supplied material is Epitalon TFA, acetate or another salt, the molecular formula, mass and potentially the CAS designation must be updated to match the CoA. Free Epitalon and salt forms should not share one technical specification.drugs.ncats+2

Pharma Research .eu: Your Premier EU Vendor for High-Purity Reagents

Pharma Research .eu can position Epitalon as a documented European laboratory reagent for analytical chemists, biochemists and laboratory managers requiring a defined tetrapeptide. The product file should include a batch-specific CoA, SDS, sequence designation, purity result, identity data, terminal-group and salt-form information, measured net content and storage instructions for both the peptide and bacteriostatic water.

Any claim that Pharma Research .eu operates an ISO 9001-certified quality-management system should be supported by a current certificate identifying the issuing body, scope and validity. Claims concerning discreet or temperature-controlled logistics across EU member states should likewise be verified for the destination, carrier route, packaging and applicable transport requirements.

A quality-focused supplier should be able to discuss:

  • Epitalon’s Ala-Glu-Asp-Gly sequence.

  • Free-peptide versus TFA, acetate or other salt form.

  • RP-HPLC purity and LC-MS identity testing.

  • Residual solvents, moisture and elemental-impurity reporting.

  • Measured net content and container-closure integrity.

  • Compatibility of bacteriostatic water with analytical workflows.

  • Storage, transport and documentation requirements.

Pharma Research .eu should therefore be described as a potential European source for research-grade Epitalon, with vendor-specific certification and logistics claims verified through current records. The material is intended strictly for controlled laboratory research and analytical use by qualified personnel under applicable institutional procedures.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Buy Epitalon 100 mg + Bacteriostatic Water”

Your email address will not be published. Required fields are marked *

Shipping & Delivery

MAECENAS IACULIS

Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.

ADIPISCING CONVALLIS BULUM

  • Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
  • Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
  • Diam parturient dictumst parturient scelerisque nibh lectus.

Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.